China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a note issued to investors on Friday. The firm set a “hold” rating on the stock.

China Pharma Trading Down 3.3 %

Shares of China Pharma stock opened at $0.19 on Friday. China Pharma has a 1 year low of $0.17 and a 1 year high of $1.16. The company’s fifty day simple moving average is $0.23 and its 200-day simple moving average is $0.24. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Articles

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.